| Bioactivity | PSMA I&T is a potent PSMA (prostate-specific membrane antigen) inhibitor. PSMA I&T can be used for SPECT/CT imaging and radionuclide therapy of prostate cancer (PCa)[1]. |
| Target | PSMA |
| Name | PSMA I&T |
| CAS | 2192281-54-0 |
| Formula | C63H92IN11O23 |
| Molar Mass | 1498.37 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Chatalic KL, et al. Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent. Theranostics. 2016 Apr 12;6(6):849-61. |
PSMA I&T
CAS: 2192281-54-0 F: C63H92IN11O23 W: 1498.37
PSMA I&T is a potent PSMA (prostate-specific membrane antigen) inhibitor. PSMA I&T can be used for SPECT/CT imaging and
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.